Actemra®

BIOLOGICAL3 trials

Sponsors

AO GENERIUM

Conditions

Healthy VolunteersRheumatoid Arthritis

Phase 1

A Safety and Pharmacokinetic Study of Complarate (Tocilizumab Biosimilar) and Actemra® in Healthy Volunteers

CompletedNCT06481202

AO GENERIUMHealthy Volunteers

Start: 2022-04-11End: 2022-08-19Updated: 2024-07-01

A Safety and Pharmacokinetics Study of Complarate (Tocilizumab Biosimilar Solution) and Actemra® in Healthy Volunteers

Active, not recruitingNCT06488521

AO GENERIUMHealthy Volunteers

Start: 2024-06-20End: 2025-09-30Target: 256Updated: 2025-07-30

Phase 3

Comparison of Complarate® (Tocilizumab Biosimilar) and Actemra® in Patients With Rheumatoid Arthritis

CompletedNCT06475508

AO GENERIUMRheumatoid Arthritis

Start: 2023-02-13End: 2024-06-11Updated: 2024-07-03

Related Papers

Comparative study of the clinical efficacy of the first domestic bioanalogue of tocilizumab based on the results of a randomized clinical trial of phase III

Modern Rheumatology Journal2024-12-13